BAY 2666605
Product Specifications
UNSPSC Description
BAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 is a PDE3A-SLFN12 complex inducer (WO2019025562A1; example 135)[1].
Target Antigen
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bay-2666605.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
FC(F)(C1=C(C2=CC=C(C=C2)F)C=CC(C([C@@H](O3)C)=NNC3=O)=C1)F
Molecular Weight
352.28
References & Citations
[1]Manuel ELLERMANN, et al. Dihydrooxadiazinones. WO2019025562A1.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145924/BAY-2666605-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145924/BAY-2666605-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
2275774-60-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
